Epigenetic mechanisms in schizophrenia

被引:1
作者
Akbarian, Schahram [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Psychiat, Friedman Brain Inst, New York, NY 10029 USA
基金
美国国家卫生研究院;
关键词
epigenome; DNA methylation; epigenetic drug target; histone modification; psychosis; prefrontal cortex;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizophrenia is a major psychiatric disorder that lacks a unifying neuropathology, while currently available pharmacological treatments provide only limited benefits to many patients. This review will discuss how the field of neuroepigenetics could contribute to advancements of the existing knowledge on the neurobiology and treatment of psychosis. Genome-scale mapping of DNA methylation, histone modifications and variants, and chromosomal loopings for promoter-enhancer interactions and other epigenetic determinants of genome organization and function are likely to provide important clues about mechanisms contributing to dysregulated expression of synaptic and metabolic genes in schizophrenia brain, including the potential links to the underlying genetic risk architecture and environmental exposures. In addition, studies in animal models are providing a rapidly increasing list of chromatin-regulatory mechanisms with significant effects on cognition and complex behaviors, thereby pointing to the therapeutic potential of epigenetic drug targets in the nervous system. (C) 2014, AICH - Servier Research Group
引用
收藏
页码:405 / 417
页数:13
相关论文
共 148 条
[51]   Converging Genetic and Functional Brain Imaging Evidence Links Neuronal Excitability to Working Memory, Psychiatric Disease, and Brain Activity [J].
Heck, Angela ;
Fastenrath, Matthias ;
Ackermann, Sandra ;
Auschra, Bianca ;
Bickel, Horst ;
Coynel, David ;
Gschwind, Leo ;
Jessen, Frank ;
Kaduszkiewicz, Hanna ;
Maier, Wolfgang ;
Milnik, Annette ;
Pentzek, Michael ;
Riedel-Heller, Steffi G. ;
Ripke, Stephan ;
Spalek, Klara ;
Sullivan, Patrick ;
Vogler, Christian ;
Wagner, Michael ;
Weyerer, Siegfried ;
Wolfsgruber, Steffen ;
de Quervain, Dominique J. -F. ;
Papassotiropoulos, Andreas .
NEURON, 2014, 81 (05) :1203-1213
[52]   Chromatin proteins and modifications as drug targets [J].
Helin, Kristian ;
Dhanak, Dashyant .
NATURE, 2013, 502 (7472) :480-488
[53]   Gene expression profile for schizophrenia - Discrete neuron transcription patterns in the entorhinal cortex [J].
Hemby, SE ;
Ginsberg, SD ;
Brunk, B ;
Arnold, SE ;
Trojanowski, JQ ;
Eberwine, JH .
ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (07) :631-640
[54]   Schizophrenia and increased risks of cardiovascular disease [J].
Hennekens, CH ;
Hennekens, AR ;
Hollar, D ;
Casey, DE .
AMERICAN HEART JOURNAL, 2005, 150 (06) :1115-1121
[55]   GAD1 mRNA Expression and DNA Methylation in Prefrontal Cortex of Subjects with Schizophrenia [J].
Huang, Hsien-Sung ;
Akbarian, Schahram .
PLOS ONE, 2007, 2 (08)
[56]   Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters [J].
Huang, Hsien-Sung ;
Matevossian, Anouch ;
Whittle, Catheryne ;
Kim, Se Young ;
Schumacher, Armin ;
Baker, Stephen P. ;
Akbarian, Schahram .
JOURNAL OF NEUROSCIENCE, 2007, 27 (42) :11254-11262
[57]   Expression of GABA Signaling Molecules KCC2, NKCC1, and GAD1 in Cortical Development and Schizophrenia [J].
Hyde, Thomas M. ;
Lipska, Barbara K. ;
Ali, Towhid ;
Mathew, Shiny V. ;
Law, Amanda J. ;
Metitiri, Ochuko E. ;
Straub, Richard E. ;
Ye, Tianzhang ;
Colantuoni, Carlo ;
Herman, Mary M. ;
Bigelow, Llewellyn B. ;
Weinberger, Daniel R. ;
Kleinman, Joel E. .
JOURNAL OF NEUROSCIENCE, 2011, 31 (30) :11088-11095
[58]   Schizophrenia: Treatment Targets Beyond Monoamine Systems [J].
Ibrahim, Hisham M. ;
Tamminga, Carol A. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011, 2011, 51 :189-209
[59]   DNA methylation of the BDNF gene and its relevance to psychiatric disorders [J].
Ikegame, Tempei ;
Bundo, Miki ;
Murata, Yui ;
Kasai, Kiyoto ;
Kato, Tadafumi ;
Iwamoto, Kazuya .
JOURNAL OF HUMAN GENETICS, 2013, 58 (07) :434-438
[60]   DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia [J].
Iwamoto, K ;
Bundo, M ;
Yamada, K ;
Takao, H ;
Iwayama-Shigeno, Y ;
Yoshikawa, T ;
Kato, T .
JOURNAL OF NEUROSCIENCE, 2005, 25 (22) :5376-5381